Laboratory tests and imaging studies in patients with cutaneous malignant melanoma

1994 Landis, 1998, Cancer statistics, 1998, CA Cancer J Clin, 48, 6, 10.3322/canjclin.48.1.6 Salopek, 1995, An estimate of the incidence of malignant melanoma in the United States: based on a survey of members of the American Academy of Dermatology, Dermatol Surg, 21, 301, 10.1016/1076-0512(94)00122-7 Provost, 1997, Laboratory tests and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians, J Am Acad Dermatol, 36, 711, 10.1016/S0190-9622(97)80323-4 1992, 143 Buzaid, 1993, Role of computed tomography in the staging of primary melanoma, J Clin Oncol, 11, 638, 10.1200/JCO.1993.11.4.638 Balch, 1992, Diagnosis of metastatic melanoma at distant sites, 439 Kelly, 1985, Frequency and duration of patient follow-up after treatment of a primary malignant melanoma, J Am Acad Dermatol, 13, 756, 10.1016/S0190-9622(85)70218-6 Markowitz, 1991, Prognosis after initial recurrence of cutaneous melanoma, Arch Surg, 126, 703, 10.1001/archsurg.1991.01410300045006 Baughan, 1993, Follow-up in stage I cutaneous malignant melanoma: an audit, Clin Oncol, 5, 174, 10.1016/S0936-6555(05)80321-8 Rigel, 1986, Importance of complete cutaneous examination for detection of malignant melanoma, J Am Acad Dermatol, 14, 857, 10.1016/S0190-9622(86)70100-X Marghoob, 1996, Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study, Br J Dermatol, 135, 704, 10.1111/j.1365-2133.1996.tb03877.x Marghoob, 1995, Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma, Cancer, 75, 707, 10.1002/1097-0142(19950115)75:2+<707::AID-CNCR2820751415>3.0.CO;2-W Huffman, 1973, Ten-year survival with multiple metastatic malignant melanoma: primary site unknown, Arch Surg, 106, 234, 10.1001/archsurg.1973.01350140090027 Hena, 1987, Effect of surgical treatment of stage IV melanoma, Am J Surg, 153, 270, 10.1016/0002-9610(87)90600-3 Wornom, 1986, Surgery as palliative treatment for distant metastases of melanoma, Ann Surg, 204, 181, 10.1097/00000658-198608000-00013 Tafra, 1995, Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax, J Thorac Cardiovasc Surg, 110, 119, 10.1016/S0022-5223(05)80017-0 Routh, 1994, Management of brain metastases: past, present, and future, South Med J, 87, 1218, 10.1097/00007611-199412000-00005 Dalgleish, 1996, The case for therapeutic vaccines: review, Melanoma Res, 6, 5, 10.1097/00008390-199602000-00002 Rogers, 1995, Boron neutron capture therapy: a promising new treatment for metastatic melanoma, Melanoma Lett, 13, 1 Petit, 1996, Complete remission seven years after treatment for metastatic malignant melanoma, Cancer, 77, 900, 10.1002/(SICI)1097-0142(19960301)77:5<900::AID-CNCR14>3.0.CO;2-7 Stoelben, 1995, Resektion von solitaren Lebermetastasen des malignen Melanoms, Chirurg, 66, 40 Overett, 1985, Surgical treatment of distant metastases: indications and results, Cancer, 56, 1222, 10.1002/1097-0142(19850901)56:5<1222::AID-CNCR2820560544>3.0.CO;2-A Ricaniadis, 1995, Gastrointestinal metastases from malignant melanoma, Surg Oncol, 4, 105, 10.1016/S0960-7404(10)80014-3 Buzaid, 1995, Role of computed tomography in the staging of patients with local-regional metastases of melanoma, J Clin Oncol, 13, 2104, 10.1200/JCO.1995.13.8.2104 Patel, 1978, Metastatic pattern of malignant melanoma: a study of 216 autopsy cases, Am J Surg, 135, 807, 10.1016/0002-9610(78)90171-X Cascinelli, 1983, Metastatic spread of stage I melanoma of the skin, Tumori, 69, 449, 10.1177/030089168306900513 Barth, 1995, Prognostic factors in 1521 melanoma patients with distant metastases, J Am Coll Surg, 181, 193 Garbe, 1995, Primary cutaneous melanoma: identification of prognostic groups and estimation of individual prognosis for 5093 patients, Cancer, 75, 2484, 10.1002/1097-0142(19950515)75:10<2484::AID-CNCR2820751014>3.0.CO;2-U 1992, NIH consensus conference. Diagnosis and treatment of early melanoma, JAMA, 268, 1314, 10.1001/jama.1992.03490100112037 Conference de Consensus, 1995, Suivi des patients operes d’un melanoma de stade I, Ann Dermatol Venereol, 122, 250 Rumke, 1992, Consensus on the management of melanoma of the skin in the Netherlands, Eur J Cancer, 28, 600, 10.1016/S0959-8049(05)80092-9 Orfanos, 1994, Stellungnahme und Empfehlungen der Kommission malignes Melanom der Deutschen dermatologishen Gesellschaft zur Diagnostik, Behandlung und Nachsorge des malignen Melanoms der Haut, Hautarzt, 45, 285, 10.1007/s001050050071 1993, Schweizerische Gesellschaft fur Dermatologie und Venereologie: das primare maligne Melanom der Haut, Bulle Med Suisse., 74, 1021 Weiss, 1995, Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas, JAMA, 274, 1703, 10.1001/jama.1995.03530210057031 Jillella, 1995, The role for close follow-up of melanoma patients with AJCC Stages I-III: a preliminary analysis, Proc Am Soc Clin Oncol, 14, 413 Ardizzoni, 1987, Stage I-II melanoma: the value of metastatic work-up, Oncology, 44, 87, 10.1159/000226451 Iscoe, 1987, Predictive value of staging: investigations in patients with clinical stage I malignant melanoma, Plast Reconstr Surg, 80, 233, 10.1097/00006534-198708000-00012 Kersey, 1985, The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma, Br J Surg, 72, 614, 10.1002/bjs.1800720810 Zartman, 1987, Metastatic disease in patients with newly diagnosed malignant melanoma, J Surg Oncol, 35, 163, 10.1002/jso.2930350304 Meyer, 1978, Pretreatment radiographic evaluation of patients with malignant melanoma, Cancer, 42, 125, 10.1002/1097-0142(197807)42:1<125::AID-CNCR2820420121>3.0.CO;2-7 Roth, 1975, Radionucleotide photoscanning: usefulness in preoperative evaluation of melanoma patients, Arch Surg, 110, 1211, 10.1001/archsurg.1975.01360160049007 Thomas, 1979, Scintiscans in the evaluation of patients with malignant melanomas, Surg Gynecol Obstet, 149, 574 Evans, 1980, Radionuclide scans not indicated for clinical stage I melanoma, Surg Gynecol Obstet, 150, 532 Au, 1984, Preoperative nuclear scans in patients with melanoma, Cancer, 53, 2095, 10.1002/1097-0142(19840515)53:10<2095::AID-CNCR2820531017>3.0.CO;2-C Jonsson, 1985, Value of liver scintigraphy in pretreatment staging and in follow-up of patients with malignant melanoma, J Surg Oncol, 29, 22, 10.1002/jso.2930290107 Muss, 1979, Radionuclide scanning in patients with advanced malignant melanoma, Clin Nucl Med, 4, 516, 10.1097/00003072-197904120-00007 Devereux, 1980, The role of bone scans in assessing malignant melanoma in patients with stage III disease, Surg Gynecol Obstet, 151, 45 Basseres, 1995, Cost-effectiveness of surveillance of Stage I melanoma: a retrospective appraisal based on a 10-year experience in a dermatology department in France, Dermatology, 191, 199, 10.1159/000246546 Khansur, 1989, Evaluation of staging workup in malignant melanoma, Arch Surg, 124, 847, 10.1001/archsurg.1989.01410070107021 Goerz, 1986, Malignant melanoma: Which examinations are useful in staging and follow-up?, Dtsch Med Wochenschr, 111, 1230, 10.1055/s-2008-1068611 Tregnaghi, 1996, Ultrasonographic evaluation of superficial lymph node metastases in melanoma, Eur J Radiol, 24, 216, 10.1016/S0720-048X(96)01102-3 Kuvshinoff, 1997, Computed tomography in evaluation of patients with stage III melanoma, Ann Surg Oncol, 4, 252, 10.1007/BF02306618 Johnson, 1997, Computed tomography in staging of patients with melanoma metastatic to the regional nodes, Ann Surg Oncol, 4, 396, 10.1007/BF02305552 Reider-Growasser, 1996, Computed tomography features of cerebral spread of malignant melanoma, Am J Clin Oncol, 19, 49, 10.1097/00000421-199602000-00011 Kostrubiak, 1988, The use of computed body tomography in malignant melanoma, JAMA, 259, 2896, 10.1001/jama.1988.03720190064033 Berman, 1993, Radiologic imaging in malignant melanoma: a review, Semin Surg Oncol, 9, 232, 10.1002/j.1098-2388.1993.tb00014.x Chalmers, 1991, The significance of pulmonary nodules detected by CT but not by chest radiography in tumour staging, Clin Radiol, 44, 410, 10.1016/S0009-9260(05)80661-0 Doiron, 1981, A comparison of noninvasive imaging modalities in the melanoma patient, Cancer, 1, 2581, 10.1002/1097-0142(19810601)47:11<2581::AID-CNCR2820471112>3.0.CO;2-8 Semelka, 1994, Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MRI imaging with fat-suppressed T2-weighted, breath-hold Tl-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences, J MRI, 4, 319 Finck, 1983, LDH and melanoma, Cancer, 51, 840, 10.1002/1097-0142(19830301)51:5<840::AID-CNCR2820510516>3.0.CO;2-7 Garg, 1979, Usefulness of an elevated serum lactate dehydrogenase value as a marker for hepatic metastases in malignant melanoma, Can Med Assoc J, 120, 1114 Campora, 1988, LDH in the follow-up of stage I malignant melanoma, Eur J Clin Oncol, 24, 277, 10.1016/0277-5379(88)90266-0 Murray, 1982, Elevated gamma-glutamyl transpeptidase levels in malignant melanoma, Cancer, 49, 1439, 10.1002/1097-0142(19820401)49:7<1439::AID-CNCR2820490721>3.0.CO;2-1 Aubert, 1977, 5-S-Cysteinyldopa in diagnosis and treatment of human malignant melanoma and ultrastructural observations, Eur J Cancer, 13, 1299, 10.1016/0014-2964(77)90039-1 Peterson, 1988, Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patient with dysplastic nevus syndrome and normal subjects, J Am Acad Dermatol, 19, 509, 10.1016/S0190-9622(88)70206-6 Hara, 1994, High plasma level of eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma, J Invest Dermatol, 102, 501, 10.1111/1523-1747.ep12373153 Yamada, 1992, Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases, Arch Dermatol, 128, 491, 10.1001/archderm.1992.01680140071005 Faraj, 1986, Plasma L-dopa in the diagnosis of malignant melanoma, Clin Chem, 32, 159, 10.1093/clinchem/32.1.159 Wraight, 1992, The use of a chelating derivative of alpha melanocyte stimulating hormone for the clinical imaging of malignant melanoma, Br J Rad, 65, 112, 10.1259/0007-1285-65-770-112 Trapeznikov, 1975, Clinical evaluation of a method of quantitative determination of homovanillic acid for the estimation of degree of tumor dissemination process in melanoma of the skin, Cancer, 36, 2064, 10.1002/cncr.2820360922 Morgan, 1974, Urine homovanillic acid and tissue dopa oxidase in patients with melanoma, Cancer, 33, 1601, 10.1002/1097-0142(197406)33:6<1601::AID-CNCR2820330619>3.0.CO;2-N Schwartze, 1994, The diagnostic significance of alpha-MSH in malignant melanoma of man, Hautarzt, 45, 468, 10.1007/s001050050106 Buzaid, 1994, Neuron-specific enolase as a tumor marker in metastatic melanoma, Am J Clin Oncol, 17, 430, 10.1097/00000421-199410000-00015 Ryan, 1981, Serum sialic acid concentrations in malignant melanoma, Eur J Cancer Clin Oncol, 17, 843, 10.1016/0014-2964(81)90242-5 Wong, 1991, Prospective evaluation of the use of antigenic-specific immune complexes in predicting the development of recurrent melanoma, Arch Surg, 126, 1450, 10.1001/archsurg.1991.01410360020004 Kagan, 1988, Gallium-67 scanning for malignant melanoma, Cancer, 61, 272, 10.1002/1097-0142(19880115)61:2<272::AID-CNCR2820610213>3.0.CO;2-V Rodot, 1994, A radiolabeled iodobenzamide for malignant melanoma staging, Melanoma Res, 4, 307, 10.1097/00008390-199410000-00007 Maffioli, 1994, Scintigraphic detection of melanoma metastases with a radiolabeled benzamide, J Nucl Med, 114, 912 Feggi, 1993, Immunoscintigraphy in malignant melanoma: a five-year clinical experience, Nucl Med Commun, 14, 145, 10.1097/00006231-199302000-00013 Boni, 1995, Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma, Dermatology, 191, 119, 10.1159/000246528 Salzillo, 1993, Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest, J Nucl Biol Med, 37, 191 Blend, 1996, Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma, J Nucl Med, 37, 252 Blend, 1992, Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients, J Clin Oncol, 10, 1330, 10.1200/JCO.1992.10.8.1330 Rogers, 1989, Advances in diagnostic technique: melanoma update, J Dermatol Surg Oncol, 15, 605, 10.1111/j.1524-4725.1989.tb03598.x Cerny, 1987, Immunoscintigraphy with 99mTc labeled F(ab')2 fragments of an antimelanoma monoclonal antibody (225.28S) in patients with metastatic malignant melanoma, Eur J Nucl Med, 13, 130, 10.1007/BF00289024 Muller, 1995, Scintigraphy with 99mTechnicium-J001X acylated polygalactoside in melanoma recurrence, Eur J Dermatol, 5, 600 Steinert, 1995, Malignant melanoma: staging with whole-body positron emission tomography and 2-(F-18)-fluoro-2-deoxy-D-glucose, Radiology, 195, 705, 10.1148/radiology.195.3.7753998 Boni, 1995, Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose, Br J Dermatol, 132, 556, 10.1111/j.1365-2133.1995.tb08711.x Boni, 1996, Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography, Arch Dermatol, 132, 875, 10.1001/archderm.1996.03890320023003 Gritters, 1993, Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose in the imaging of malignant melanoma, J Nucl Med, 34, 1420 Damian, 1996, Positron emission tomography in the detection and management of metastatic melanoma, Melanoma Res, 6, 325, 10.1097/00008390-199608000-00008 Blessing, 1995, Positron emission tomography and ultrasonography: a comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma, Arch Dermatol, 131, 1394, 10.1001/archderm.1995.01690240048008 Wagner, 1997, Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma, J Surg Oncol, 64, 181, 10.1002/(SICI)1096-9098(199703)64:3<181::AID-JSO2>3.0.CO;2-6 Guo, 1995, Clinical significance of serum S100 in metastatic malignant melanoma, Eur J Cancer, 31, 924, 10.1016/0959-8049(95)00087-9 Henze, 1997, Serum S100: a marker for disease monitoring in metastatic melanoma, Dermatology, 194, 208, 10.1159/000246103 Curry, 1996, Detection and quantification of melanoma cells in the circulation of patients, Melanoma Res, 6, 45, 10.1097/00008390-199602000-00007 Battayani, 1995, Polymerase chain reaction detection of circulating melanocytes as a prognostic in patients with melanoma, Arch Dermatol, 131, 443, 10.1001/archderm.1995.01690160071011 Wang, 1994, Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma, Ann Surg, 220, 768, 10.1097/00000658-199412000-00010 Jung, 1997, Evaluation of tyrosinase mRNA as a tumor marker in blood of melanoma patients, J Clin Oncol, 15, 2826, 10.1200/JCO.1997.15.8.2826 Glaser, 1997, Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable marker in melanoma patients: a clinical two-center study, J Clin Oncol, 15, 2818, 10.1200/JCO.1997.15.8.2818 Hoon, 1995, Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay, J Clin Oncol, 13, 2109, 10.1200/JCO.1995.13.8.2109 Hanekom, 1997, An improved and combined reverse transcription–polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood, Melanoma Res, 7, 111, 10.1097/00008390-199704000-00004 Schandendorf, 1995, P-glycoprotein expression in primary and metastatic malignant melanoma, Br J Dermatol, 132, 551, 10.1111/j.1365-2133.1995.tb08710.x Gritzmann, 1987, Sonographie bei zervikalen Lymphknoten-metastasen, Radiologie, 27, 118 Stutte, 1989, Lymph node sonography in the care of malignant melanoma, Hautarzt, 40, 344 Fornage, 1989, Sonographic detection and fine-needle aspiration biopsy of nonpalpable recurrent or metastatic melanoma in subcutaneous tissues, J Ultrasound Med, 8, 421, 10.7863/jum.1989.8.8.421 Balch, 1992, An analysis of prognostic factors in 8500 patients with cutaneous melanoma, 165 Sirott, 1993, Prognostic factors in patients with metastatic malignant melanoma: a multivariate analysis, Cancer, 72, 3091, 10.1002/1097-0142(19931115)72:10<3091::AID-CNCR2820721034>3.0.CO;2-V Houghton, 1992, Treatment for advanced melanoma, 468 Heaston, 1983, Solitary pulmonary metastases in high-risk melanoma patients: a prospective comparison of conventional and computed tomography, Am J Roentgenol, 141, 169, 10.2214/ajr.141.1.169 Horgan, 1993, Staging of melanoma, Clin Radiol, 48, 297, 10.1016/S0009-9260(05)81234-6 Stutte, 1989, Ultrasonographic diagnosis of melanoma metastases in liver, gallbladder, and spleen, J Ultrasound Med, 8, 541, 10.7863/jum.1989.8.10.541 al-Sheneber, 1996, Small-bowel resection for metastatic melanoma, Can J Surg, 39, 199 Brady, 1997, Sentinel lymph node evaluation in melanoma, Arch Dermatol, 133, 1014, 10.1001/archderm.1997.03890440096014 Morton, 1992, Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch Surg, 127, 392, 10.1001/archsurg.1992.01420040034005 Reintgen, 1997, Recent advances in the care of the patient with malignant melanoma, Ann Surg, 225, 1, 10.1097/00000658-199701000-00001 Reintgen, 1997, The adjuvant treatment of malignant melanoma, J Fla Med Assoc, 84, 147 Thompson, 1995, Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes, Melanoma Res, 5, 255, 10.1097/00008390-199508000-00008 Breslow, 1970, Thickness, cross sectional areas and depth of invasion in the prognosis of cutaneous melanoma, Ann Surg, 172, 902, 10.1097/00000658-197011000-00017